Privia Health director sells 135,498 shares
Privia Health Group, Inc. director Matthew Shawn Morris reported exercising stock options and selling common shares in coordinated transactions.
Rhea-AI Filing Summary
Privia Health Group, Inc. director Matthew Shawn Morris reported exercising stock options and selling common shares in coordinated transactions. He exercised a total of 135,498 options at an exercise price of $2.00 per share and sold 135,498 common shares in open-market trades.
The sales, totaling 135,498 shares, were executed at weighted-average prices around the mid‑$20s per share under a previously adopted Rule 10b5-1 trading plan, indicating a pre-arranged program rather than discretionary timing. Morris retains a meaningful direct and indirect equity interest, including shares held through Emerald Family, LLC and a trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 135,498 shares ($3.30M approx. pre-tax spread)
Exercise and Sale
9 txns
Insider
Morris Matthew Shawn
Role
Director
Sold
135,498 shs ($3.57M)
Approx. gross sale proceeds
$3.57M
Approx. exercise cost
$271K
Approx. pre-tax spread
$3.30M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 82,675 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 82,675 | $2.00 | $165K |
| Sale | Common Stock, par value $0.01 per share | 45,634 | $26.52 | $1.21M |
| Sale | Common Stock, par value $0.01 per share | 37,041 | $26.93 | $998K |
| Exercise | Stock Option (Right to Purchase) | 52,823 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.01 per share | 52,823 | $2.00 | $106K |
| Sale | Common Stock, par value $0.01 per share | 52,823 | $25.72 | $1.36M |
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 3,387,381 contracts (Direct);
Common Stock, par value $0.01 per share — 76,651 shares (Direct);
Common Stock, par value $0.01 per share — 11,998 shares (Indirect, By Trust);
Common Stock, par value $0.01 per share — 12,487 shares (Indirect, By Emerald Family, LLC)
Footnotes (5)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. All of the stock options are fully vested and exercisable.
Key Figures
Shares sold: 135,498 shares
Options exercised: 135,498 shares
Exercise price: $2.00 per share
+4 more
7 metrics
Shares sold
135,498 shares
Total common shares sold in open-market transactions
Options exercised
135,498 shares
Common shares acquired through stock option exercises
Exercise price
$2.00 per share
Stock option exercise/conversion price
Sale price range (bucket 1)
$25.15–$26.03
Weighted-average sale price range referenced in footnote
Sale price range (bucket 2)
$25.81–$26.80
Weighted-average sale price range referenced in footnote
Sale price range (bucket 3)
$26.81–$27.09
Weighted-average sale price range referenced in footnote
Option expiration
2033-08-27
Expiration date for the exercised stock options
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Purchase), derivative security
4 terms
Rule 10b5-1 trading plan financial
"This transaction was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Purchase) financial
"security_title: "Stock Option (Right to Purchase)""
derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Privia Health (PRVA) director Matthew Shawn Morris report in this Form 4?
He reported exercising 135,498 stock options and selling 135,498 common shares in open-market transactions. The activity reflects an exercise-and-sell pattern, converting options with a $2.00 exercise price into cash while maintaining an ongoing equity stake.
Were the Privia Health (PRVA) insider sales made under a Rule 10b5-1 plan?
Yes. A footnote states the transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan. Such plans pre-arrange trades, making the timing more mechanical and reducing the information content of when sales occur.
What options did Matthew Shawn Morris exercise in this Privia Health (PRVA) filing?
He exercised stock options covering 135,498 shares of common stock at a $2.00 exercise price. The related derivative entries describe fully vested, exercisable options with an expiration date in 2033, which were converted into common shares then sold.
AI-generated analysis. How Rhea-AI works. Not financial advice.
